The Journal of Alzheimer's Disease (JAD) is a renowned international journal that focuses on advancing our understanding of Alzheimer's disease. This multidisciplinary journal covers various aspects of the disease, including its etiology, pathogenesis, epidemiology, genetics, behavior, treatment, and psychology. JAD publishes a wide range of content, including research reports, reviews, systematic reviews, short communications, hypotheses, commentaries, editorials, ethics reviews/responses, and book reviews.

It also provides a platform for letters-to-the-editor and blogs. The journal is committed to fostering original research and facilitating the dissemination of knowledge about Alzheimer's disease. The editorial policy of JAD ensures rigorous review and evaluation of manuscripts to maintain high standards of quality.

The journal operates under the guidance of an esteemed editorial board and associate editors with expertise in the field. JAD has an impressive Impact Factor of 4. 0, indicating its significance in the scientific community.

Its broad audience comprises basic science researchers and clinicians specializing in Alzheimer's disease and related disorders. The journal is published by IOS Press, a reputable publisher that serves the information needs of scientific and medical communities worldwide. With its comprehensive coverage and commitment to excellence, JAD plays a crucial role in advancing Alzheimer's disease research and treatment